Theravance Unveils Separation Plans and Initiates Dividend As Q1 Loss Widens 81%

Theravance outlines its upcoming split into two separate companies and initiates a quarterly stipend in lieu of reporting a wider first-quarter loss.

May 6, 2014 at 6:51PM

Things are about to getting very exciting for existing shareholders of biopharmaceutical company Theravance (NASDAQ:THRX), with the company announcing its first-quarter results after the closing bell and setting a record date of May 15 for its split into two separate trading entities.

For the quarter, Theravance recorded net revenue of just $0.2 million, down from $1.3 million in the prior-year period. Vibativ product sales totaled $0.9 million and royalty revenue from the sale of Relvar and Breo Ellipta totaled $0.7 million. However, revenue was also offset by amortized expenses tied to intangible assets.

As you might have guessed, with a full lineup of clinical studies ongoing, Theravance's research and development and selling, general, and administrative expenses soared. R&D expenses rose to $43.4 million from $26.4 million in the prior year, while SG&A costs more than doubled to $22.8 million from $8.3 million.

Net loss for the quarter widened by 81% to $67.7 million, or $0.62 per share from $37.4 million, or $0.39 per share in the previous year.

Two additional developments dominated Theravance's report.

First, given Thervance's strong cash position of $430.8 million as of the end of the quarter, it plans to initiate a $0.25-per-quarter cash dividend. This would place a projected forward yield of 3.7% on Theravance based on today's closing price.

Secondly, Theravance set the course for its upcoming split into two companies: Royalty Management Co., consisting of its FDA-approved COPD assets and other collaborations under partnership with GlaxoSmithKline (NYSE:GSK), and Theravance BioPharma, consisting of every other therapeutic indication in its pipeline. Shareholders on record as of May 15 will receive Theravance BioPharma shares in the form of dividend by June 2.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information